Provectus Biopharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
15,696.20
17,391.60
14,178.90
1,165.70
105.50
51
Total Accounts Receivable
-
733.30
500.00
300.00
452.40
595.30
Other Current Assets
-
978.00
41.20
360.60
400.40
370.20
Total Current Assets
15,696.20
19,102.90
14,720.10
1,826.30
958.30
1,016.50
Net Property, Plant & Equipment
30.10
92.20
85.10
72.00
86.60
72.50
Long-Term Note Receivable
-
3,378.30
2,695.00
1,471.20
821.20
-
Intangible Assets
4,254.80
3,583.70
2,912.60
2,241.50
1,570.30
899.20
Other Assets
27.00
27.00
27.00
-
-
-
Total Assets
20,008.20
26,184.20
20,439.80
5,611.00
3,436.40
1,988.20
Accounts Payable
348.90
-
-
-
3,270.50
Other Current Liabilities
164.10
847.70
4,122.90
2,141.80
728.70
Total Current Liabilities
512.90
847.70
4,122.90
2,141.80
3,999.20
Long-Term Debt
-
-
-
-
9,456.00
Other Liabilities
12,866.60
146.60
-
-
-
Total Liabilities
13,379.50
994.30
4,122.90
2,141.80
13,455.20
Common Equity (Total)
6,628.60
25,189.90
16,316.90
3,469.20
10,018.80
Total Shareholders' Equity
6,628.70
25,189.90
16,316.90
3,469.20
10,018.80
Total Equity
6,628.70
25,189.90
16,316.90
3,469.20
10,018.80
Liabilities & Shareholders' Equity
20,008.20
26,184.20
20,439.80
5,611.00
3,436.40
Preferred Stock (Carrying Value)
0.00
-
-
0.00
-
About Provectus Biopharmaceuticals
View Profile
